DÜSSELDORF, Germany, Feb. 24, 2026 (GLOBE NEWSWIRE) — Accesa has been awarded Top Supplier Retail 2026 in the Customer Experience category, together with MediaMarktSaturn, Europe’s leading consumer electronics retailer. Presented by the EHI Retail Institute… Read More »Accesa Wins Top Supplier Retail 2026 for AI-Powered Customer Experience – in Partnership with MediaMarktSaturn
The ROG Flow Z13-KJP gaming tablet reflects the true spirit of play and discovery, as symbolized by Ludens, now available for pre-order in Canada KEY POINTS Cutting-edge gaming hardware meets visionary storytelling: ROG joins forces… Read More »ASUS Republic of Gamers and KOJIMA PRODUCTIONS Unveil the ROG Flow Z13-KJP, Available for Pre-Order
Proposed Nasdaq-listed AI company achieves key regulatory milestone as merger with Check-Cap targets first half of 2026; $30M growth facility available ISFIYA, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) — Check-Cap Ltd. (NASDAQ: MBAI) (“Check-Cap” or… Read More »MBody AI and Check Cap Ltd. ($MBAI) Submit Nasdaq Listing Application for Merger Close
Beacon enables shoppers and trade professionals to find lighting by uploading a photo, replacing keyword search with visual discovery Selinsgrove, Pennsylvania, United States, February 24, 2026 — Lighting New York, a leading online destination for… Read More »Lighting New York Launches Beacon, an AI-Powered Visual Light Finder That Transforms How Customers Discover Lighting
Dux-Soup has released its latest B2B Lead Generation Report 2026. London, England, United Kingdom, February 24, 2026 — Dux-Soup has released its latest B2B Lead Generation Report 2026, which reveals how B2B marketing strategies have… Read More »Dux-Soup releases 2026 B2B lead generation report
Mordor Intelligence has published a new report on critical ischemia treatment market offering a comprehensive analysis of trends, growth drivers, and future projections. Hyderabad, Telangana, India, February 24, 2026 — Critical Ischemia Treatment Market Analysis … Read More »Critical Ischemia Treatment Market to Reach USD 7.03 Billion by 2031, Driven by Rising Peripheral Artery Disease Cases and Growing Adoption of Endovascular Procedures